| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | -6.33M | 94.52M | -2.33M | -300.67M | 224.47M |
| Gross Profit | -8.04M | 87.29M | -11.51M | -305.79M | 213.01M |
| EBITDA | -8.90M | 86.48M | -3.11M | -295.22M | 223.36M |
| Net Income | -9.04M | 86.32M | -15.75M | -295.89M | 223.33M |
Balance Sheet | |||||
| Total Assets | 508.10M | 606.30M | 586.04M | 643.67M | 956.87M |
| Cash, Cash Equivalents and Short-Term Investments | 30.88M | 43.89M | 24.33M | 58.79M | 25.22M |
| Total Debt | 0.00 | 0.00 | 306.00K | 0.00 | 0.00 |
| Total Liabilities | 6.49M | 10.39M | 10.12M | 10.31M | 21.72M |
| Stockholders Equity | 501.62M | 595.91M | 575.92M | 633.36M | 935.15M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 86.61M | 6.88M | 39.04M | -101.02M |
| Operating Cash Flow | 222.00K | 86.61M | 6.88M | 39.04M | -101.02M |
| Investing Cash Flow | 71.48M | 59.59M | -9.21M | 93.85M | -138.88M |
| Financing Cash Flow | -85.25M | -66.68M | -41.54M | -4.79M | 114.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £3.54B | 9.24 | 6.50% | 7.21% | -7.11% | 0.45% | |
76 Outperform | £195.09M | 4.34 | 12.32% | 8.15% | 1.29% | 11.17% | |
74 Outperform | £805.37M | 8.25 | 11.49% | 2.70% | -4.38% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | £149.23M | 11.47 | 9.72% | 21.31% | -15.65% | -12.27% | |
50 Neutral | ― | 8.48 | 0.44% | 2.93% | -141.34% | -151.52% |